Evaluation of Product Switching After a State Medicaid Program Began Covering Loratadine OTC 1 Year After Market Availability

OBJECTIVES: The conversion of loratadine from prescription (Rx)-only to over-the-counter (OTC) status on November 27, 2002, brought about the question of how OTC products may influence utilization of both OTC and Rx-only low-sedating antihistamines (LSAs) simultaneously. North Carolina (NC) Medicaid...

Descripción completa

Detalles Bibliográficos
Autores principales: Trygstad, Troy K., Hansen, Richard A., Wegner, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438017/
https://www.ncbi.nlm.nih.gov/pubmed/16515369
http://dx.doi.org/10.18553/jmcp.2006.12.2.108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438017/
https://www.ncbi.nlm.nih.gov/pubmed/16515369
http://dx.doi.org/10.18553/jmcp.2006.12.2.108

Ejemplares similares